About Me

I'm a partner in the Intellectual Property Group based in London specialising in contentious patent matters with a particular focus and keen interest in the life sciences and healthcare sector.

Over the years, my particular expertise and focus has been developed through my involvement in and management of numerous commercially important, multi-jurisdictional and technically complex cases mainly in the field of pharmaceutical/biological patents for both innovator and generic clients up to the Supreme Court.

I have also built up complementary experience in advising and supporting our clients in a range of sectors in relation to their multi-jurisdictional patent portfolio management and strategy (including associated proceedings/enforcement and commercialisation), freedom to operate/validity and infringement analyses, specific regulatory considerations and IP due diligence and disclosure in corporate transactions.

I enjoy working in a team to develop strategy as well as getting into the detail of both technical and legal aspects. I have extensive experience collaborating with colleagues across our network as well as with other external advisors, technical experts and client personnel.

To assist in the effective collaboration, implementation and management of various projects, we work closely with clients in the development of e-tools and I have particular experience in tailoring our Access portal tool in the patent commercialisation context.

In recent years, I have also supported two multinational pharma clients on secondment in-house managing a heavy and diverse multi-jurisdictional workload spanning commercial, regulatory and IP litigation matters. This valuable experience has enabled me to gain a deeper understanding of the different business functions, the pharmaceutical regulatory regime and the varying public policy and health system issues which have become increasingly relevant to European patent/SPC litigation and strategy. I am also better placed to understand the pressures faced by our clients, the pragmatism needed to align legal and commercial objectives and what is most needed from an external adviser.
  • Patents:
  • Fisher & Paykel Healthcare (EvaquaTM)
  • Teva (Copaxone®, Abiraterone, Melatonin prolonged-release)
  • Honeywell (refrigerants including R-1234ze and R-1234yf)
  • Actavis (Pemetrexed, Pregabalin, Tadalafil, Telmisartan, Entacapone, Pramipexole, Fluvastatin and Finasteride)
  • Gedeon Richter (Drospirenone)
  • Baxter Healthcare Corp (Sevoflurane)
  • Warner-Lambert Company/Pfizer (Lipitor®)
  • Trade mark, Design and Copyright:
  • Mattel (MyScene Barbie dolls vs Bratz)
  • Sir Robert McAlpine Ltd (Alfred McAlpine's rebranding)
  • Globe GB Limited (side designs on shoes vs Gola)


  • University of Durham, BSc in Cell Biology
  • College of Law, London, PGDL & LPC
  • University of Bristol, Postgraduate Diploma in Intellectual Property


  • The Law Society of England & Wales in 2004
Testimonials Carousel Megaphone


Named Rising IP Star

MIP Stars

Latest insights

More Insights

The latest developments and hearings at the UPC: C-Kore v Novawell

Feb 19 2024

Read More
City skyline at dusk

Second judicial interpretation of Actavis: Court expresses different views on "normal interpretation" but follows Mylan

Nov 13 2017

Read More

What's on TwoBirds TV?

More Videos